Increased excitation-inhibition balance due to a loss of GABAergic synapses in the serine racemase knockout model of NMDA receptor hypofunction
暂无分享,去创建一个
J. A. Gray | A. McAllister | Shekib A. Jami | Scott Cameron | J. M. Wong | Emily R. Daly | A. | Kimberley McAllister
[1] J. Belforte,et al. Early NMDA Receptor Ablation in Interneurons Causes an Activity-Dependent E/I Imbalance in vivo in Prefrontal Cortex Pyramidal Neurons of a Mouse Model Useful for the Study of Schizophrenia. , 2021, Schizophrenia bulletin.
[2] J. Billard,et al. Serine Racemase Deletion Affects the Excitatory/Inhibitory Balance of the Hippocampal CA1 Network , 2020, International journal of molecular sciences.
[3] J. Coyle,et al. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction , 2020, Scientific Reports.
[4] J. Coyle,et al. Postsynaptic Serine Racemase Regulates NMDA Receptor Function , 2020, The Journal of Neuroscience.
[5] D. Javitt,et al. Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout mice , 2020, bioRxiv.
[6] C. Zold,et al. Interneuron NMDA Receptor Ablation Induces Hippocampus-Prefrontal Cortex Functional Hypoconnectivity after Adolescence in a Mouse Model of Schizophrenia , 2020, The Journal of Neuroscience.
[7] K. Nakazawa,et al. The origin of NMDA receptor hypofunction in schizophrenia. , 2020, Pharmacology & therapeutics.
[8] J. Rubenstein,et al. Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders , 2019, Molecular Psychiatry.
[9] D. Feldman,et al. Increased Excitation-Inhibition Ratio Stabilizes Synapse and Circuit Excitability in Four Autism Mouse Models , 2018, Neuron.
[10] W. Lu,et al. Genetic deletion of NMDA receptors suppresses GABAergic synaptic transmission in two distinct types of central neurons , 2018, Neuroscience Letters.
[11] Brian R. Lee,et al. Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method , 2018, Journal of visualized experiments : JoVE.
[12] J. A. Gray,et al. Long-Term Depression Is Independent of GluN2 Subunit Composition , 2018, The Journal of Neuroscience.
[13] K. Ressler,et al. Serine Racemase and D-serine in the Amygdala Are Dynamically Involved in Fear Learning , 2018, Biological Psychiatry.
[14] Zachary B. Loris,et al. Enhanced astrocytic D-serine underlies synaptic damage after traumatic brain injury , 2017, The Journal of clinical investigation.
[15] A. Grace,et al. Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia , 2017, Molecular Psychiatry.
[16] J. Glausier,et al. GABA and schizophrenia: Where we stand and where we need to go , 2017, Schizophrenia Research.
[17] K. Nakazawa,et al. Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia , 2017, npj Schizophrenia.
[18] J. Coyle,et al. The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis , 2016, Trends in Neurosciences.
[19] V. Sohal. How Close Are We to Understanding What (if Anything) γ Oscillations Do in Cortical Circuits? , 2016, The Journal of Neuroscience.
[20] T. Weickert,et al. Biological Psychology : Stress , 2016 .
[21] S. Anderson,et al. D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability , 2016, Front. Cell. Neurosci..
[22] W. Lu,et al. An NMDA Receptor-Dependent Mechanism Underlies Inhibitory Synapse Development. , 2016, Cell reports.
[23] K. Deisseroth,et al. Prefrontal Parvalbumin Neurons in Control of Attention , 2016, Cell.
[24] J. Coyle,et al. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia , 2016, Neuropsychopharmacology.
[25] L. Dobrunz,et al. Interneuron Transcriptional Dysregulation Causes Frequency-Dependent Alterations in the Balance of Inhibition and Excitation in Hippocampus , 2015, The Journal of Neuroscience.
[26] Renee Hoch,et al. Gamma Rhythms Link Prefrontal Interneuron Dysfunction with Cognitive Inflexibility in Dlx5/6 +/− Mice , 2015, Neuron.
[27] Rachel S White,et al. Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability , 2015, Biological Psychiatry.
[28] E. Kavalali. The mechanisms and functions of spontaneous neurotransmitter release , 2014, Nature Reviews Neuroscience.
[29] Raquel E. Gur,et al. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia , 2014, Molecular Psychiatry.
[30] J. Coyle,et al. Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction , 2014, Neurochemistry International.
[31] S. Snyder,et al. Serine Racemase Regulated by Binding to Stargazin and PSD-95 , 2014, The Journal of Biological Chemistry.
[32] Y. T. Wang,et al. The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse , 2014, Front. Cell. Neurosci..
[33] J. Coyle,et al. d-Serine and Serine Racemase are Localized to Neurons in the Adult Mouse and Human Forebrain , 2014, Cellular and Molecular Neurobiology.
[34] S. Barrow,et al. MHCI Requires MEF2 Transcription Factors to Negatively Regulate Synapse Density during Development and in Disease , 2013, The Journal of Neuroscience.
[35] S. Snyder,et al. d-Serine in Glia and Neurons Derives from 3-Phosphoglycerate Dehydrogenase , 2013, The Journal of Neuroscience.
[36] Stefan Kasicki,et al. A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo , 2013, Journal of psychopharmacology.
[37] J. Coyle,et al. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction , 2013, Proceedings of the National Academy of Sciences.
[38] Bernardo L. Sabatini,et al. Excitatory/Inhibitory Synaptic Imbalance Leads to Hippocampal Hyperexcitability in Mouse Models of Tuberous Sclerosis , 2013, Neuron.
[39] Mark Ellisman,et al. The Cell-Autonomous Role of Excitatory Synaptic Transmission in the Regulation of Neuronal Structure and Function , 2013, Neuron.
[40] S. Siegel,et al. Knockout of NMDA Receptors in Parvalbumin Interneurons Recreates Autism‐Like Phenotypes , 2013, Autism research : official journal of the International Society for Autism Research.
[41] G. McCarthy,et al. Relationship of Resting Brain Hyperconnectivity and Schizophrenia-like Symptoms Produced by the NMDA receptor Antagonist Ketamine in Humans , 2012, Molecular Psychiatry.
[42] Yuko Fujita,et al. Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice , 2012, Epilepsy Research.
[43] J. Coyle. NMDA receptor and schizophrenia: a brief history. , 2012, Schizophrenia bulletin.
[44] S. Siegel,et al. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? , 2012, Genes, brain, and behavior.
[45] A. Stan,et al. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. , 2012, Current pharmaceutical biotechnology.
[46] Masahiko Watanabe,et al. NMDA Receptors in GABAergic Synapses during Postnatal Development , 2012, PloS one.
[47] Anthony J. Rissling,et al. Hierarchical Organization of Gamma and Theta Oscillatory Dynamics in Schizophrenia , 2012, Biological Psychiatry.
[48] Viktoriya D. Nikolova,et al. Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice , 2012, Developmental Neuroscience.
[49] D. Bannerman,et al. GluN1 hypomorph mice exhibit wide-ranging behavioral alterations , 2012, Genes, brain, and behavior.
[50] S. Siegel,et al. NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia , 2012, Neurobiology of Disease.
[51] H. M. Morris,et al. Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia , 2012, Neuropharmacology.
[52] J. Coyle,et al. Cell Selective Conditional Null Mutations of Serine Racemase Demonstrate a Predominate Localization in Cortical Glutamatergic Neurons , 2012, Cellular and Molecular Neurobiology.
[53] D. Lewis,et al. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. , 2012, Schizophrenia bulletin.
[54] J. Coyle,et al. The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex , 2012, Neurobiology of Disease.
[55] R. Nicoll,et al. Distinct Modes of AMPA Receptor Suppression at Developing Synapses by GluN2A and GluN2B: Single-Cell NMDA Receptor Subunit Deletion In Vivo , 2011, Neuron.
[56] S. Nelson,et al. A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex , 2011, Neuron.
[57] D. Lewis,et al. GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia , 2011, Neural plasticity.
[58] Masahiko Watanabe,et al. NMDA Receptors in Hippocampal GABAergic Synapses and Their Role in Nitric Oxide Signaling , 2011, The Journal of Neuroscience.
[59] Jessica A. Cardin,et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior , 2011, Molecular Psychiatry.
[60] R. Semba,et al. Localization of d-serine and serine racemase in neurons and neuroglias in mouse brain , 2011, Neurological Sciences.
[61] H. Eichenbaum,et al. Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology , 2011, Genes, brain, and behavior.
[62] J. Coyle,et al. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers , 2011, Neuroscience Letters.
[63] Hannah Monyer,et al. NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory , 2010, Neuron.
[64] M. Buuse. Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects , 2010 .
[65] S. Oliet,et al. Long term potentiation depends on release of D-serine from astrocytes , 2009, Nature.
[66] R. Gur,et al. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia , 2009, Genes, brain, and behavior.
[67] T. Sejnowski,et al. Cortical Enlightenment: Are Attentional Gamma Oscillations Driven by ING or PING? , 2009, Neuron.
[68] M. Nicolelis,et al. Hyperdopaminergia and NMDA Receptor Hypofunction Disrupt Neural Phase Signaling , 2009, The Journal of Neuroscience.
[69] E. Ginns,et al. Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia , 2009, Biological Psychiatry.
[70] Anthony A Grace,et al. A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia , 2009, The Journal of Neuroscience.
[71] Rita Zemankovics,et al. Maintaining network activity in submerged hippocampal slices: importance of oxygen supply , 2009, The European journal of neuroscience.
[72] Benjamin W. H. Lim,et al. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars , 2008, Proceedings of the National Academy of Sciences.
[73] J. Ehmsen,et al. Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior , 2008, Molecular Psychiatry.
[74] Athar N. Malik,et al. Activity-dependent regulation of inhibitory synapse development by Npas4 , 2008, Nature.
[75] K. Sakimura,et al. Serine racemase is predominantly localized in neurons in mouse brain , 2008, The Journal of comparative neurology.
[76] H. M. Morris,et al. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. , 2008, Cerebral cortex.
[77] H. M. Morris,et al. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia , 2008, Neurotoxicity Research.
[78] H. Lipp,et al. Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor Function , 2008, Neuropsychopharmacology.
[79] A. Vaccarino,et al. Evaluation of morphine analgesia and motor coordination in mice following cortex-specific knockout of the N-methyl-d-aspartate NR1-subunit , 2008, Neuroscience Letters.
[80] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.
[81] Elliot S. Gershon,et al. Allelic association of G72/G30 with schizophrenia and bipolar disorder: A comprehensive meta-analysis , 2008, Schizophrenia Research.
[82] T. Deerinck,et al. Regulation of spine morphology and spine density by NMDA receptor signaling in vivo , 2007, Proceedings of the National Academy of Sciences.
[83] B. Moghaddam,et al. NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons , 2007, The Journal of Neuroscience.
[84] S. Noda,et al. The serine racemase mRNA is predominantly expressed in rat brain neurons. , 2007, Archives of histology and cytology.
[85] M. Matsushita,et al. A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.
[86] R. Panizzutti,et al. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia , 2007, Schizophrenia Research.
[87] J. Lieberman,et al. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction , 2006, Pharmacology Biochemistry and Behavior.
[88] F. McMahon,et al. G72/G30 in Schizophrenia and Bipolar Disorder: Review and Meta-analysis , 2006, Biological Psychiatry.
[89] S. Oliet,et al. Glia-Derived d-Serine Controls NMDA Receptor Activity and Synaptic Memory , 2006, Cell.
[90] Elena Kartvelishvily,et al. Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors* , 2006, Journal of Biological Chemistry.
[91] Sheryl S. Moy,et al. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function , 2006, Brain Research.
[92] L. Abramova,et al. Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia , 2006, Molecular Psychiatry.
[93] Ramin V. Parsey,et al. Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.
[94] Chih-Chiang Chiu,et al. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. , 2005, Archives of general psychiatry.
[95] R. Fradley,et al. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating , 2005, Behavioural Brain Research.
[96] B. Kampa,et al. Synaptic integration in dendritic trees. , 2005, Journal of neurobiology.
[97] D. Lewis,et al. Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.
[98] Daniel C. Javitt,et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia , 2005, Biological Psychiatry.
[99] J. Meier,et al. GluR‐ and TrkB‐mediated maturation of GABAA receptor function during the period of eye opening , 2005, The European journal of neuroscience.
[100] Dean V. Buonomano,et al. Timing and Balance of Inhibition Enhance the Effect of Long-Term Potentiation on Cell Firing , 2004, The Journal of Neuroscience.
[101] J. Lieberman,et al. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function , 2004, Behavioural Brain Research.
[102] Robert F. Miller,et al. D‐Serine as a glial modulator of nerve cells , 2004, Glia.
[103] Jorge V. José,et al. Inhibitory synchrony as a mechanism for attentional gain modulation , 2004, Journal of Physiology-Paris.
[104] Bita Moghaddam,et al. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[105] D. Lewis,et al. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.
[106] J. Storm-Mathisen,et al. GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission , 2004, Molecular and Cellular Neuroscience.
[107] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[108] D. Lorrain,et al. Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.
[109] R. Panizzutti,et al. Neurobiology through the looking-glass: d-serine as a new glial-derived transmitter , 2002, Neurochemistry International.
[110] E. Jodo,et al. Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats , 2002, Neuroscience.
[111] J. Lieberman,et al. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function , 2002, Brain Research.
[112] P. Sham,et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[113] F. Golley,et al. Structure and Function , 2002, Science's STKE.
[114] Fred H. Gage,et al. Adeno-associated virus effectively mediates conditional gene modification in the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[115] C. Tamminga,et al. Effects of Ketamine in Normal and Schizophrenic Volunteers , 2001, Neuropsychopharmacology.
[116] R. Gainetdinov,et al. Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.
[117] Susumu Tonegawa,et al. Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex , 2000, Nature.
[118] D. Linden,et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[119] G. Rosoklija,et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. , 2000, Archives of general psychiatry.
[120] M. Colonnese,et al. Chronic NMDA exposure accelerates development of GABAergic inhibition in the superior colliculus. , 2000, Journal of neurophysiology.
[121] M. Ekker,et al. A Highly Conserved Enhancer in the Dlx5/Dlx6Intergenic Region is the Site of Cross-Regulatory Interactions betweenDlx Genes in the Embryonic Forebrain , 2000, The Journal of Neuroscience.
[122] S H Snyder,et al. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Pierri,et al. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia , 1999, Biological Psychiatry.
[124] Marc G Caron,et al. Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.
[125] Nicholas Lange,et al. D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.
[126] O. Paulsen,et al. Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro , 1998, Nature.
[127] J. Kauer,et al. Properties of carbachol-induced oscillatory activity in rat hippocampus. , 1997, Journal of neurophysiology.
[128] Anil K Malhotra,et al. Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.
[129] R. Roth,et al. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.
[130] Bita Moghaddam,et al. Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.
[131] S. Snyder,et al. d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors , 1997, The Journal of Neuroscience.
[132] F. Vollenweider,et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.
[133] S. Tonegawa,et al. The Essential Role of Hippocampal CA1 NMDA Receptor–Dependent Synaptic Plasticity in Spatial Memory , 1996, Cell.
[134] K. I. Blum,et al. Impaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice , 1996, Cell.
[135] M. Hasselmo,et al. NMDA-dependent modulation of CA1 local circuit inhibition , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[136] Masahiko Watanabe,et al. Impairment of Suckling Response, Trigeminal Neuronal Pattern Formation, and Hippocampal LTD in NMDA Receptor ε2 Subunit Mutant Mice , 1996, Neuron.
[137] L. Benardo,et al. Recruitment of GABAA inhibition in rat neocortex is limited and not NMDA dependent. , 1995, Journal of neurophysiology.
[138] Carol A. Tamminga,et al. Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.
[139] S. Snyder,et al. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[140] D R Medoff,et al. Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.
[141] E. Costa,et al. Exposure of neuronal cultures to K+ depolarization or to N-methyl-d-aspartate increases the transcription of genes encoding the α1 and α 5 GABAA receptor subunits , 1995 .
[142] J. Connor,et al. Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death , 1994, Neuron.
[143] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[144] Susumu Tonegawa,et al. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice , 1994, Cell.
[145] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[146] H. Wigström,et al. Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition , 1983, Nature.
[147] J. Coyle,et al. The Role of Serine Racemase in the Pathophysiology of Brain Disorders. , 2018, Advances in pharmacology.
[148] A. Ivanov,et al. Hippocampus In Vitro , 2017 .
[149] M. van den Buuse. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. , 2010, Schizophrenia bulletin.
[150] A. Ramsey. NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. , 2009, Progress in brain research.
[151] P. Jonas,et al. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks , 2007, Nature Reviews Neuroscience.
[152] Peter Jonas,et al. Patch-clamp recording from mossy fiber terminals in hippocampal slices , 2006, Nature Protocols.
[153] T. Sejnowski,et al. Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5–2 Hz), theta (5–12 Hz), and gamma (35–70 Hz) bands , 2000, Hippocampus.
[154] A. Malhotra,et al. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.
[155] W Singer,et al. Visual feature integration and the temporal correlation hypothesis. , 1995, Annual review of neuroscience.
[156] E. Costa,et al. Exposure of neuronal cultures to K+ depolarization or to N-methyl-D-aspartate increases the transcription of genes encoding the alpha 1 and alpha 5 GABAA receptor subunits. , 1995, Brain Research. Molecular Brain Research.